Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients / Chongguan Ng en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.4 (Abril)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 491-498 Título : Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients : A four-week, randomized, double-blinded, placebo-controlled study Tipo de documento: texto impreso Autores: Chongguan Ng, Autor ; Marco P.M. Boks, Autor ; Kit Roes, Autor Fecha de publicación: 2021 Artículo en la página: pp. 491-498 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer Resumen: This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methylphenidate as add-on therapy to mirtazapine compared to placebo for treatment of depression in terminally ill cancer patients. Link: ./index.php?lvl=notice_display&id=26968 [artículo] Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients : A four-week, randomized, double-blinded, placebo-controlled study [texto impreso] / Chongguan Ng, Autor ; Marco P.M. Boks, Autor ; Kit Roes, Autor . - 2021 . - pp. 491-498. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 491-498 Palabras clave: Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer Resumen: This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methylphenidate as add-on therapy to mirtazapine compared to placebo for treatment of depression in terminally ill cancer patients. Link: ./index.php?lvl=notice_display&id=26968

---

1 (1 - 1 / 1)